Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorKHANAFER, Nagham
dc.contributor.authorHEMMENDINGER, Anaelle
dc.contributor.authorGUERY, Benoit
dc.contributor.authorVACHEE, Anne
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorROGUES, Anne-Marie
dc.contributor.authorGRAVET, Alain
dc.contributor.authorBOUTOILLE, David
dc.contributor.authorVANJAK, Dominique
dc.contributor.authorBARBUT, Frederic
dc.contributor.authorVANHEMS, Philippe
dc.date.accessioned2021-04-02T13:13:48Z
dc.date.available2021-04-02T13:13:48Z
dc.date.issued2021-02
dc.identifier.issn1095-8274 (Electronic) 1075-9964 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26865
dc.description.abstractEnINTRODUCTION: The magnitude and scope of Clostridioides difficile infection (CDI) has changed with an increase in incidence and severity. The epidemiology of CDI is not well known in France due to difficulties to conduct large continuous surveillance. The objectives were to compare the characteristics of patients with CDI collected through repeated point prevalence survey via DIFTEC™, a free electronic tool, with those from previous French or European studies. METHODS: DIFTEC™ was developed to evaluate epidemiological burden, diagnostic strategies and management of CDI in France. National and European guidelines were used for definitions. A literature review of studies conducted in Western Europe on CDI and published between January, 2008 and May, 2018 was done to compare their data with those included in the DIFTEC™ database. RESULTS: From January 2016, to December 2017, 455 CDI episodes from 22 French hospitals were included. Most of CDI cases were health-care associated (HCA) (78%). The comparison between included patients and French literature data showed that the rates of previous antibiotics exposure, crude mortality and recurrence were not statistically different. However HCA-CDI was significantly more frequent in the DIFTEC™ study. Gender distribution, recurrence and crude mortality rates were not statistically different compared to European data. HCA-CDI was more frequent in the DIFTEC™ study whereas previous treatment with proton pump inhibitors and antibiotics were significantly higher in European studies. DISCUSSION: These results illustrated the added value of a new tool for increasing the reliable knowledge of CDI in France based on epidemiological surveillance implemented in health-care settings.
dc.language.isoENen_US
dc.subjectClostridioides difficile infection
dc.subjectFrance
dc.subjectPrevalence
dc.subjectSurveillance
dc.title.enEstablishment of a French surveillance system of Clostridiodes difficile infection: Comparison of patient's characteristics with other national and European data
dc.title.alternativeAnaerobeen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.anaerobe.2021.102329en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33540110en_US
bordeaux.journalAnaerobeen_US
bordeaux.page102329en_US
bordeaux.volume69en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAstellas Pharmaen_US
hal.identifierhal-03188866
hal.version1
hal.date.transferred2021-04-02T13:13:52Z
hal.audienceInternationale
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Anaerobe&rft.date=2021-02&rft.volume=69&rft.spage=102329&rft.epage=102329&rft.eissn=1095-8274%20(Electronic)%201075-9964%20(Linking)&rft.issn=1095-8274%20(Electronic)%201075-9964%20(Linking)&rft.au=KHANAFER,%20Nagham&HEMMENDINGER,%20Anaelle&GUERY,%20Benoit&VACHEE,%20Anne&ROGUES,%20Anne-Marie&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée